论文部分内容阅读
在公立医院试点医药分家的背景下,国家对医疗服务价格和财政补贴规模作出了相应调整。真实的医疗服务成本是合理确定医疗服务价格的基本前提。依据Loeb-Magat激励型管制理论,政府对公立医院医疗服务的补贴应该为医疗服务消费者剩余与一次性总付税之差,价格管制部门应该以边际成本为基础对公立医院医疗服务进行定价。这一机制设计可以真实地反映出公立医院的医疗服务成本并赋予公立医院对于医疗服务定价权和剩余索取权,使其能够在追求自身利益最大化的定价过程中实现社会福利最大化。
In the context of piloting pharmaceuticals in public hospitals, the state has made corresponding adjustments to the prices of medical services and the scale of financial subsidies. The true cost of medical services is a reasonable prerequisite for determining the price of medical services. According to Loeb-Magat’s incentive-based regulation theory, government subsidies for public hospital medical services should be the difference between medical service consumer surplus and one-time total tax, and price control departments should price public hospital medical services on the basis of marginal cost. The design of this mechanism can truly reflect the cost of medical services in public hospitals and give public hospitals the right of pricing and residual claims for medical services so that they can maximize the social welfare in the process of pricing their own interests.